Cargando…

The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients

Acute myeloid leukemia (AML) is a hematologic malignancy characterized by abnormal proliferation and a lack of differentiation of myeloid blasts. Considering the dismal prognosis this disease presents, several efforts have been made to better classify it and offer a tailored treatment to each subtyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasca, Sergiu, Turcas, Cristina, Jurj, Ancuta, Teodorescu, Patric, Iluta, Sabina, Hotea, Ionut, Bojan, Anca, Selicean, Cristina, Fetica, Bogdan, Petrushev, Bobe, Moisoiu, Vlad, Zimta, Alina-Andreea, Sas, Valentina, Constantinescu, Catalin, Zdrenghea, Mihnea, Dima, Delia, Tomuleasa, Ciprian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277399/ https://www.ncbi.nlm.nih.gov/pubmed/32365516 http://dx.doi.org/10.3390/diagnostics10050263

Ejemplares similares

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
por: Turcas, Cristina, et al.
Publicado: (2020)

A narrative review of central nervous system involvement in acute leukemias
por: Deak, Dalma, et al.
Publicado: (2021)

Persistent Basophilia May Suggest an “Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia
por: Dobrowolski, Jerome, et al.
Publicado: (2019)

The Potential Equivalents of TET2 Mutations
por: Pasca, Sergiu, et al.
Publicado: (2021)

TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia
por: Pasca, Sergiu, et al.
Publicado: (2020)

Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia
por: Deak, Dalma, et al.
Publicado: (2019)

MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases
por: Pasca, Sergiu, et al.
Publicado: (2020)

SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome
por: Moisoiu, Vlad, et al.
Publicado: (2021)

B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?
por: Desmirean, Minodora, et al.
Publicado: (2020)

Approach to the Adult Acute Lymphoblastic Leukemia Patient
por: Sas, Valentina, et al.
Publicado: (2019)

Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
por: Griesel, Carla, et al.
Publicado: (2020)

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
por: Iluta, Sabina, et al.
Publicado: (2021)

Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
por: Moisoiu, Vlad, et al.
Publicado: (2019)

The Predictive Role of Modified Early Warning Score in 174 Hematological Patients at the Point of Transfer to the Intensive Care Unit
por: Constantinescu, Catalin, et al.
Publicado: (2021)

Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease
por: Iluta, Sabina, et al.
Publicado: (2022)

Current therapeutic approaches in the management of hemophilia—a consensus view by the Romanian Society of Hematology
por: Hotea, Ionut, et al.
Publicado: (2021)

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
por: Tomuleasa, Ciprian, et al.
Publicado: (2018)

Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR–ABL transcripts
por: Dima, Delia, et al.
Publicado: (2017)

Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid, Following Combination Chemotherapy with Etoposide Plus COP
por: Iluta, Sabina, et al.
Publicado: (2020)

Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma
por: Deak-Mihaly, Dalma, et al.
Publicado: (2021)

Transforming growth factor β‐mediated micromechanics modulates disease progression in primary myelofibrosis
por: Teodorescu, Patric, et al.
Publicado: (2020)

Correlation between the prevalence of T-cell lymphomas and alcohol consumption
por: Desmirean, Minodora, et al.
Publicado: (2021)

Extramedullary Hematopoiesis of the Liver and Spleen
por: Cenariu, Diana, et al.
Publicado: (2021)

Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
por: Petrushev, Bobe, et al.
Publicado: (2016)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
por: Pasca, Sergiu, et al.
Publicado: (2019)

Targeting the Microenvironment in MDS: The Final Frontier
por: Teodorescu, Patric, et al.
Publicado: (2020)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Genetically enhanced T lymphocytes and the intensive care unit
por: Tat, Tiberiu, et al.
Publicado: (2018)

Correction: Genetically enhanced T lymphocytes and the intensive care unit
por: Tat, Tiberiu, et al.
Publicado: (2018)

Paraneoplastic hypereosinophilia in a patient with peripheral T cell lymphoma, not otherwise specified
por: Desmirean, Minodora, et al.
Publicado: (2019)

The use of rotation to fentanyl in cancer-related pain
por: Dima, Delia, et al.
Publicado: (2017)

The Possible Non-Mutational Causes of FVIII Deficiency: Non-Coding RNAs and Acquired Hemophilia A
por: Zimta, Alina-Andreea, et al.
Publicado: (2021)

Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells
por: Mesaros, Oana, et al.
Publicado: (2020)

Protein dysregulation in graft versus host disease
por: Qian, Liren, et al.
Publicado: (2017)

Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Mechanistic Insights in Hemophagocytic Lymphohistiocytosis: Subsequent Acute Hepatic Failure in a Multiple Myeloma Patient Following Therapy with Ixazomib-Lenalidomide-Dexamethasone
por: Constantinescu, Catalin, et al.
Publicado: (2022)

Bicytopenia as a paraneoplastic syndrome for pseudomyxoma peritonei. Hematologic manifestations of a subtle disease
por: Tomuleasa, Ciprian, et al.
Publicado: (2015)

In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice
por: Berce, Cristian, et al.
Publicado: (2016)

Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases
por: Radu, Letitia-Elena, et al.
Publicado: (2020)

Advances in the treatment of newly diagnosed primary central nervous system lymphomas
por: Qian, Liren, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jg5qnrh1auvoei3j77hqrdk8mh